首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1391981

免疫細胞工程市場：按細胞類型、副產品、按適應症、按應用、按最終用戶、按地區

Immune Cell Engineering Market, By Cell Type, By Product, By Disease Indication, By Application, By End User, By Geography

出版日期: 2023年11月03日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

免疫細胞工程的全球市場規模預計將從 2023 年的 28.2 億美元增至 2030 年的 116.6 億美元，預測期內年複合成長率為 22.5%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	28.2億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	22.50%	2030年市場規模預測	116.6億美元

圖 1. 2023 年免疫細胞技術的全球市場佔有率(%)（按地區）

免疫細胞工程是近年來受到廣泛關注的領域，因為它有可能徹底改變包括癌症在內的各種疾病的治療。免疫細胞工程涉及對免疫細胞的操縱和修飾，以提高其靶向和破壞癌細胞和其他病原體的能力。這個新領域結合了免疫學、分子生物學和基因工程的原理來開發創新的治療方法。

免疫系統在識別和消除體內外來入侵者和異常細胞方面發揮著重要作用。然而，針對某些疾病的免疫反應可能不足或無效。透過對免疫細胞進行基因改造，科學家可以提高其識別和攻擊特定目標（例如癌細胞）的能力。

市場動態：

免疫細胞工程市場由幾個關鍵因素驅動。首先，癌症、自體自體免疫疾病、感染疾病等多種疾病的盛行率不斷增加。這些疾病的常規治療方法通常有局限性，因此需要創新的治療方法。

其次，基因編輯技術的進步顯著提高了免疫細胞工程的效率和精確度。 CRISPR/Cas9 等基因編輯工具使修改免疫細胞變得更加容易，從而增加了其治療潛力。這些技術創新預計將推動免疫細胞工程市場的成長。

然而，也存在一些需要解決的挑戰和阻礙因素。主要挑戰之一是免疫細胞工程治療的高成本。這些治療方法的開發和製造流程非常複雜，需要專門的設施和專業知識。這限制了這些治療方法的可用性，特別是在新興國家。

例如，2022年12月，製藥公司吉利德科學公司宣布收購臨床階段生物技術公司Tmunity Therapeutics Inc.。透過此次收購，吉利德科學將獲得臨床前和臨床項目，包括一個「裝甲」CAR T技術平台，該平台有潛力應用於多種CAR T細胞，以增強抗腫瘤活性，並有助於加強產品製造流程。

本研究的主要特點

該報告詳細分析了全球免疫細胞工程市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球免疫細胞技術市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、經營團隊升級、市場擴張和行銷策略做出資訊的決策。
全球免疫細胞工程市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球免疫細胞工程市場的各種策略矩陣，將促進相關人員的決策。

介紹
北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東南亞國協
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第11章競爭形勢

Thermo Fisher Scientific,Inc.
Merck KGaA
Danaher Corporation
Lonza
Miltenyi Biotec
Takara Bio Inc.
Sartoroius CellGenix GmbH
FUJIFILM Irvine Scientific
Agilent Technologies,Inc.
Bio-Techne
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Charles River Laboratories
Creative Bioarray
Sartorius AG
Novogene Co, Ltd.
AGC Biologics
Catalent, Inc
WuXi AppTec
Discovery Life Sciences

第12章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6350

The global immune cell engineering market size is expected to reach US$ 11.66 Bn by 2030, from US$ 2.82 Bn in 2023, at a CAGR of 22.5% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 2.82 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	22.50%	2030 Value Projection:	US$ 11.66 Bn

Figure 1. Global Immune Cell Engineering Market Share (%), By Region, 2023

Immune cell engineering is a field that has gained significant attention in recent years due to its potential to revolutionize the treatment of various diseases, including cancer. It involves the manipulation and modification of immune cells to enhance their ability to target and destroy cancer cells or other pathogens. This emerging field combines principles of immunology, molecular biology, and genetic engineering to develop innovative therapies.

The immune system plays a critical role in recognizing and eliminating foreign invaders or abnormal cells in the body. However, in some cases, the immune response may be insufficient or ineffective against certain diseases. By genetically modifying immune cells, scientists can enhance their ability to recognize and attack specific targets, such as cancer cells.

Market Dynamics:

The immune cell engineering market is driven by several key factors. Firstly, there is a growing prevalence of various diseases, including cancer, autoimmune disorders, and infectious diseases. As traditional treatment options for these diseases often have limitations, there is a need for innovative therapeutic approaches.

Secondly, advancements in gene-editing technologies have significantly improved the efficiency and precision of immune cell engineering. Gene-editing tools such as CRISPR/Cas9 have made it easier to modify immune cells and enhance their therapeutic potential. These technological innovations are expected to drive the growth of the immune cell engineering market.

However, there are also several challenges and restraints that need to be addressed. One of the main challenges is the high cost associated with immune cell engineering therapies. The development and manufacturing processes for these therapies are complex and require specialized facilities and expertise. This has limited the accessibility of these therapies, particularly in developing countries.

For instance, in December 2022, Gilead Sciences, Inc., a pharmaceutical company, announced the acquisition of Tmunity Therapeutics Inc., a clinical-stage biotechnology company. The acquisition provided Gilead Sciences, Inc. with preclinical and clinical programs, including an "armored" CAR T technology platform that has the potential to be applied to a variety of CAR T cells to enhance anti-tumor activity, and helps to enhance manufacturing processes for of CAR T cells product.

Key features of the study:

This report provides in-depth analysis of the global immune cell engineering market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global immune cell engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza, Miltenyi Biotec, Takara Bio Inc., Sartoroius CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technologies, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Charles River Laboratories, Creative Bioarray, Sartorius AG, Novogene Co, Ltd., AGC Biologics, Catalent, Inc., WuXi AppTec, Discovery Life Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global immune cell engineering market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immune cell engineering market

Detailed Segmentation:

Global Immune Cell Engineering Market, By Cell Type
- T Cells
- NK Cells
- Dendritic Cells
- Tumor Cells
- Stem Cells
- Others
Global Immune Cell Engineering Market, By Product
- Consumables
- Instruments
- Software
Global Immune Cell Engineering Market, By Disease Indication
- Cardiovascular Diseases
- Respiratory Diseases
- Infectious Diseases
- Cancer
- Neurological Diseases
- Others
Global Immune Cell Engineering Market, By Application
- Research Applications
- Cell Therapy & Regenerative Medicine
- Others
Global Immune Cell Engineering Market, By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Academic & Research Institutes
- Cell Banks
- Others
Global Immune Cell Engineering Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Top companies in Immune Cell Engineering Market:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Lonza
- Miltenyi Biotec
- Takara Bio Inc.
- Sartoroius CellGenix GmbH
- FUJIFILM Irvine Scientific
- Agilent Technologies, Inc.
- Bio-Techne
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson and Company
- Charles River Laboratories
- Creative Bioarray
- Sartorius AG
- Novogene Co, Ltd.
- AGC Biologics
- Catalent, Inc
- WuXi AppTec
- Discovery Life Sciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Immune Cell Engineering Market, By Cell Type
- Market Immune Cell Engineering Market, By Product
- Market Immune Cell Engineering Market, By Disease Indication
- Market Immune Cell Engineering Market, By Application
- Market Immune Cell Engineering Market, By End User
- Market Immune Cell Engineering Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Immune Cell Engineering Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Immune Cell Engineering Market , By Cell Type, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
NK Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Dendritic Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Tumor Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Immune Cell Engineering Market , By Product, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Immune Cell Engineering Market , By Disease Indication, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Neurological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Immune Cell Engineering Market , By Application, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cell Therapy & Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Immune Cell Engineering Market , By End User, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cell Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

10. Immune Cell Engineering Market , By Region, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U..K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
South Africa
North Africa
Central Africa

11. Competitive Landscape

Thermo Fisher Scientific,Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
Danaher Corporation
Lonza
Miltenyi Biotec
Takara Bio Inc.
Sartoroius CellGenix GmbH
FUJIFILM Irvine Scientific
Agilent Technologies,Inc.
Bio-Techne
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Charles River Laboratories
Creative Bioarray
Sartorius AG
Novogene Co, Ltd.
AGC Biologics
Catalent, Inc
WuXi AppTec
Discovery Life Sciences
Analyst Views